Charles Schwab Trust Co Lowers Position in CVS Health Co. (NYSE:CVS)

Charles Schwab Trust Co lowered its stake in CVS Health Co. (NYSE:CVS) by 22.6% during the 4th quarter, Holdings Channel reports. The institutional investor owned 7,056 shares of the pharmacy operator’s stock after selling 2,064 shares during the quarter. Charles Schwab Trust Co’s holdings in CVS Health were worth $317,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. MidAtlantic Capital Management Inc. purchased a new stake in CVS Health in the 3rd quarter worth $25,000. Ridgewood Investments LLC raised its stake in CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 450 shares during the period. Livelsberger Financial Advisory purchased a new position in CVS Health in the 3rd quarter worth approximately $31,000. Legacy Investment Solutions LLC bought a new stake in shares of CVS Health during the third quarter valued at approximately $31,000. Finally, Reston Wealth Management LLC purchased a new position in shares of CVS Health in the third quarter worth $32,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Stock Up 1.5 %

CVS stock opened at $52.72 on Tuesday. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. CVS Health Co. has a one year low of $43.56 and a one year high of $80.75. The firm’s fifty day moving average is $51.34 and its 200 day moving average is $56.32. The firm has a market cap of $66.35 billion, a PE ratio of 13.38, a P/E/G ratio of 0.79 and a beta of 0.59.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $0.01. The company had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. CVS Health’s revenue was up 6.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.21 EPS. On average, research analysts forecast that CVS Health Co. will post 5.22 EPS for the current year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be given a $0.665 dividend. The ex-dividend date is Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 5.05%. CVS Health’s payout ratio is currently 67.51%.

Analysts Set New Price Targets

CVS has been the subject of a number of research analyst reports. Cantor Fitzgerald restated a “neutral” rating and set a $62.00 price objective on shares of CVS Health in a research report on Tuesday, October 1st. Mizuho cut their target price on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a report on Thursday, October 24th. UBS Group lifted their price objective on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research note on Thursday, November 7th. StockNews.com cut shares of CVS Health from a “hold” rating to a “sell” rating in a research report on Thursday, November 14th. Finally, Evercore ISI upped their price target on shares of CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a report on Tuesday, October 8th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $68.71.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.